Claim your FREE Gift & Newsletter. Just enter your... E-MAIL ADDRESS

First Name

Then

Don't worry -- your e-mail address is totally secure.
I promise to use it only to send you Prospering With Arthritis.


Get Back Into the Swing of Things!

Get the Best Bang for Your Buck... Click Here

If  this website was helpful, 
Please
Click below to... 
   


Joint Pain Forum – News you can use!

back to Arthritis News articles


Roche says repeated MabThera treatment helps rheumatoid arthritis symptoms



June 13, 2007

Roche Holdings AG said new data shows relief from rheumatoid arthritis symptoms is 'sustained or further improved' by repeated use over several years of its rheumatism drug MabThera.

The data also showed that MabThera remains safe to use after as many as seven courses of treatment at 6-12 month intervals, the company said in a statement published at an annual meeting of the European League Against Rheumatism (EULAR).

Roche said 1,053 rheumatoid arthritis patients who previously did not adequately respond to other drugs were treated with MabThera, and almost 70 pct of the patients used the drug for more than two years.






A quarter of patients who did not respond to treatment with a drug called tumor necrosis factor (TNF) inhibitors showed a 70 pct improvement in symptoms when treated with MabThera repeatedly, compared with only 11 pct while treated with TNF inhibitors.

The number of patients achieving remission doubled to 12 pct, Roche said. Patients previously treated with disease-modifying anti-rheumatic drug (DMARD) showed a remission rate that rose to 14 pct from 5 pct.

Rheumatoid arthritis is an autoimmune disease characterized by inflammation that leads to stiff, swollen and painful joints.

back to Arthritis News articles













Bookmark This Page...
AddThis Social Bookmark Button
                                                

MEMBERS AREA | Site Map | CONTACT US
Privacy | Terms

About Us